SCHEMBL2145890

SCHEMBL2145890

COCCO[C@@H]1CCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 2/20 0.47
WDR77 Q9BQA1 2/20 0.47
PIK3CD O00329 3/20 0.44
HPGD P15428 1/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
RECQL P46063 1/20 0.42
EPHX1 P07099 1/20 0.42
PDE4B Q07343 2/20 0.41
USP30 Q70CQ3 1/20 0.41
NR1H2 P55055 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.41
PDE4A P27815 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
USP2 O75604 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2145886 1.00 PRMT5 (0.47) PRMT5WDR77PIK3CDHPGDALDH1A1
SCHEMBL16333183 0.96 PRMT5 (0.44) PRMT5WDR77PIK3CDHPGDALDH1A1
SCHEMBL16333181 0.96 PRMT5 (0.44) PRMT5WDR77PIK3CDHPGDALDH1A1
SCHEMBL14392671 0.92 MEN1 (0.50) PRMT5WDR77PIK3CDHPGDALDH1A1
SCHEMBL792038 0.91 HPGD (0.49) PRMT5WDR77HPGDALDH1A1MAPT
SCHEMBL7847383 0.88 NR1H2 (0.49) PRMT5WDR77PIK3CDHPGDALDH1A1
SCHEMBL15362664 0.87 HPGD (0.46) PRMT5WDR77HPGDALDH1A1MAPT
SCHEMBL16419551 0.87 PRMT5 (0.47) PRMT5WDR77PIK3CDHPGDALDH1A1
SCHEMBL16415212 0.87 PRMT5 (0.47) PRMT5WDR77PIK3CDHPGDALDH1A1
SCHEMBL16520107 0.87 PRMT5 (0.47) PRMT5WDR77PIK3CDHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same FUJIFILM CORPORATION (JP) 2021-11-02 US disclosed
EP-3604301-B1 4-PYRIDONE COMPOUND OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION AND FORMULATION INCLUDING SAME FUJIFILM CORP (JP) 2021-09-22 EP disclosed
EP-3604301-A1 4-PYRIDONE COMPOUND OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION AND FORMULATION INCLUDING SAME FUJIFILM Corporation (JP) 2020-02-05 EP disclosed
WO-2017017630-A1 NOVEL BETULINIC SUBSTITUTED AMIDE DERIVATIVES AS HIV INHIBITORS HETERO RESEARCH FOUNDATION (IN) 2017-02-02 WO disclosed
WO-2011088045-A1 AURORA KINASE COMPOUNDS AND METHODS OF THEIR USE AMBIT BIOSCIENCES CORPORATION (US) 2011-07-21 WO disclosed
WO-2006032342-A2 CARBONYL COMPOUND-CONTAINING DRUG AND THE USE THEREOF MERCK PATENT GMBH (DE) 2006-03-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same HAVCR2, HBS1L, PHKB PRMT5 1867/4885WDR77 590/4885PIK3CD 897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.